Human menopausal gonadotropin versus recombinant follicle-stimulating hormone in normogonadotropic women down-regulated with a gonadotropin-releasing hormone agonist who were undergoing in vitro fertilization and intracytoplasmic sperm injection: a prospective randomized study

Author： Westergaard L.G.   Erb K.   Laursen S.B.   Rex S.   Rasmussen P.E.  

Publisher： Elsevier

ISSN： 0015-0282

Source： Fertility and Sterility, Vol.76, Iss.3, 2001-09, pp. : 543-549

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Ovarian response and in vitro fertilization outcome in patients with reduced ovarian reserve who were stimulated with recombinant follicle-stimulating hormone or human menopausal gonadotropin

By Meo F.   Ranieri D.M.   Khadum I.   Serhal P.  

Fertility and Sterility, Vol. 77, Iss. 3, 2002-03 ,pp. : 630-632

Elsevier

Access to resources Recommend Favorite

Recombinant follicle-stimulating hormone versus human menopausal gonadotropin in the late follicular phase during ovarian hyperstimulation for in vitro fertilization

By Commenges-Ducos M.   Piault S.   Papaxanthos A.   Ribes C.   Dallay D.   Commenges D.  

Fertility and Sterility, Vol. 78, Iss. 5, 2002-11 ,pp. : 1049-1054

Elsevier

Access to resources Recommend Favorite

Comparison of stimulation with clomiphene citrate in combination with recombinant follicle-stimulating hormone and recombinant luteinizing hormone to stimulation with a gonadotropin-releasing hormone agonist protocol: a prospective, randomized study

By Weigert M.   Krischker U.   Pohl M.   Poschalko G.   Kindermann C.   Feichtinger W.  

Fertility and Sterility, Vol. 78, Iss. 1, 2002-07 ,pp. : 34-39

Elsevier

Access to resources Recommend Favorite

A prospective randomized comparison of routine buserelin acetate and a decreasing dosage of nafarelin acetate with a low-dose gonadotropin-releasing hormone agonist protocol for in vitro fertilization and intracytoplasmic sperm injection

By Takeuchi S.   Minoura H.   Shibahara T.   Tsuiki Y.   Noritaka F.   Toyoda N.  

Fertility and Sterility, Vol. 76, Iss. 3, 2001-09 ,pp. : 532-537

Elsevier

Access to resources Recommend Favorite

Efficacy and safety of highly purified menotropin versus recombinant follicle-stimulating hormone in in vitro fertilization/intracytoplasmic sperm injection cycles: a randomized, comparative trial

By The European and Israeli Study Group on Highly Purified Menotropin versus Recombinant Follicle-Stimulating Hormone  

Fertility and Sterility, Vol. 78, Iss. 3, 2002-09 ,pp. : 520-528

Elsevier

Access to resources Recommend Favorite